Participants 446 650 7
METHODS Forty-two patients with carcinoma in situ of the bladder were randomized to intravesical BCG (21 patients) or mitomycin C plus doxorubicin sequential therapy (21 patients) as first line treatment.
Participants 755 813 5
Of the patients, 27 had grade 2 and 15 had grade 3 cancer.
